COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation?
出版年份 2021 全文链接
标题
COVID-19 vaccination followed by activation of glomerular diseases: does association equal causation?
作者
关键词
COVID-19, glomerulonephritis, kidney biopsy
出版物
KIDNEY INTERNATIONAL
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2021-09-14
DOI
10.1016/j.kint.2021.09.002
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases
- (2021) Aristo Vojdani et al. Frontiers in Immunology
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2021) Zhiwei Wu et al. LANCET INFECTIOUS DISEASES
- Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial
- (2021) Raches Ella et al. LANCET INFECTIOUS DISEASES
- Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
- (2021) Larissa Lebedev et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
- (2021) Rutger J. Maas et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant Recipients
- (2021) Brian J. Boyarsky et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A case of gross hematuria and IgA nephropathy flare-up following SARS-CoV-2 vaccination
- (2021) Shab E. Gul Rahim et al. KIDNEY INTERNATIONAL
- Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine
- (2021) Vivette D. D’Agati et al. KIDNEY INTERNATIONAL
- Relapse of Primary Membranous Nephropathy after inactivated SARS-CoV-2 Virus Vaccination
- (2021) Mehmet Fethullah Aydin et al. KIDNEY INTERNATIONAL
- Minimal change disease relapse following SARS-CoV2 mRNA vaccine
- (2021) Delphine Kervella et al. KIDNEY INTERNATIONAL
- Timing of COVID-19 Vaccine in the Setting of Anti-CD20 Therapy: A Primer for Nephrologists
- (2021) Sam Kant et al. Kidney International Reports
- Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine
- (2021) Hirotaka Komaba et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- IgA nephropathy presenting as macroscopic hematuria in 2 pediatric patients after receiving the Pfizer COVID-19 vaccine
- (2021) Christian Hanna et al. KIDNEY INTERNATIONAL
- Anti-GBM nephritis with mesangial IgA deposits after SARS-CoV-2 mRNA vaccination
- (2021) Allan Sacker et al. KIDNEY INTERNATIONAL
- Relapse of IgG4-related nephritis following mRNA COVID-19 vaccine
- (2021) Christophe Masset et al. KIDNEY INTERNATIONAL
- Is COVID-19 vaccination unmasking glomerulonephritis?
- (2021) Hui Zhuan Tan et al. KIDNEY INTERNATIONAL
- Histologic correlates of gross hematuria following Moderna COVID-19 vaccine in patients with IgA nephropathy
- (2021) Satoru Kudose et al. KIDNEY INTERNATIONAL
- ANCA glomerulonephritis after the Moderna COVID-19 vaccination
- (2021) Arjun Sekar et al. KIDNEY INTERNATIONAL
- Gross hematuria following vaccination for severe acute respiratory syndrome coronavirus 2 in 2 patients with IgA nephropathy
- (2021) Lavinia Negrea et al. KIDNEY INTERNATIONAL
- De novo vasculitis after mRNA-1273 (Moderna) vaccination
- (2021) Manuel A. Anderegg et al. KIDNEY INTERNATIONAL
- Minimal change disease following the Moderna mRNA-1273 SARS-CoV-2 vaccine
- (2021) Amy Holzworth et al. KIDNEY INTERNATIONAL
- Gross hematuria following SARS-CoV-2 vaccination in patients with IgA nephropathy
- (2021) Peggy Perrin et al. KIDNEY INTERNATIONAL
- Relapse of minimal change disease following the AstraZeneca COVID-19 vaccine
- (2021) Clare Morlidge et al. KIDNEY INTERNATIONAL
- Letter regarding “Minimal change disease relapse following SARS-CoV-2 mRNA vaccine”
- (2021) Nora Schwotzer et al. KIDNEY INTERNATIONAL
- Post-vaccinal minimal change disease
- (2021) Jari Weijers et al. KIDNEY INTERNATIONAL
- SARS-CoV-2 mRNA vaccines induce persistent human germinal centre responses
- (2021) Jackson S. Turner et al. NATURE
- Three Doses of an mRNA Covid-19 Vaccine in Solid-Organ Transplant Recipients
- (2021) Nassim Kamar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
- (2021) Mark G. Thompson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human IgG and IgA responses to COVID-19 mRNA vaccines
- (2021) Adam V. Wisnewski et al. PLoS One
- On the molecular determinants of the SARS-CoV-2 attack
- (2020) Darja Kanduc et al. CLINICAL IMMUNOLOGY
- Kidney Biopsy Findings in Patients with COVID-19
- (2020) Satoru Kudose et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Neurological associations of COVID-19
- (2020) Mark A Ellul et al. LANCET NEUROLOGY
- COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses
- (2020) Ugur Sahin et al. NATURE
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 mRNA Vaccines Foster Potent Antigen-Specific Germinal Center Responses Associated with Neutralizing Antibody Generation
- (2020) Katlyn Lederer et al. IMMUNITY
- T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
- (2020) Katie J. Ewer et al. NATURE MEDICINE
- Increased PD-1 + CD154 + Tfh cells are possibly the most important functional subset of PD-1 + T follicular helper cells in adult patients with minimal change disease
- (2018) Tao Li et al. MOLECULAR IMMUNOLOGY
- Cytokine disturbances in systemic lupus erythematosus
- (2011) Noam Jacob et al. ARTHRITIS RESEARCH & THERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More